Description

11H-Pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-4,11-dicarboxylic acid, 6-cyclopropyl-1-fluoro-3,6,8,9,9a,10,12,13-octahydro-3-oxo-, 11-(1,1-diMethylethyl) 4-ethyl ester is a complex, high-purity heterocyclic organic compound designed for advanced research and development. This molecule serves as a critical pharmaceutical intermediate or building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents, particularly in areas requiring sophisticated molecular architectures.

Application

• Pharmaceutical Intermediate: Key building block in the research and synthesis of novel drug candidates, especially for central nervous system (CNS) or anti-infective therapies.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core structural component in the development of new proprietary APIs.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Process Chemistry & Scale-Up: Employed in route scouting and optimization for the commercial-scale manufacturing of complex molecules.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and development services for the pharmaceutical industry.

Basic Information

Product Name	11H-Pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-4,11-dicarboxylic acid, 6-cyclopropyl-1-fluoro-3,6,8,9,9a,10,12,13-octahydro-3-oxo-, 11-(1,1-diMethylethyl) 4-ethyl ester
CAS No.	1271982-21-8
Molecular Formula	C26H29FN2O6
Molecular Weight	484.52 g/mol
Synonyms	6-Cyclopropyl-1-fluoro-3,6,8,9,9a,10,12,13-octahydro-3-oxo-11H-pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-4,11-dicarboxylic acid 11-tert-butyl 4-ethyl ester; 1271982-21-8; tert-Butyl 6-cyclopropyl-1-fluoro-3-oxo-4-(ethoxycarbonyl)-3,6,8,9,9a,10,12,13-octahydro-11H-pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-11-carboxylate; Ethyl 6-cyclopropyl-1-fluoro-3-oxo-11-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9,9a,10,12,13-octahydro-11H-pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-4-carboxylate
EINECS	Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under strict quality control protocols to ensure batch-to-batch consistency and reliability. All materials are characterized using advanced analytical techniques including HPLC, NMR, and MS. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Single Maximum Impurity	≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.